OneMedNet (NASDAQ:ONMD) Director Thomas Kosasa Buys 55,000 Shares

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 55,000 shares of the stock in a transaction dated Monday, June 16th. The shares were bought at an average price of $0.38 per share, with a total value of $20,900.00. Following the completion of the acquisition, the director directly owned 8,480,824 shares of the company’s stock, valued at approximately $3,222,713.12. This represents a 0.65% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Thomas Kosasa also recently made the following trade(s):

• On Wednesday, September 24th, Thomas Kosasa purchased 6,000 shares of OneMedNet stock. The shares were purchased at an average cost of $0.93 per share, for a total transaction of $5,580.00.
• On Friday, August 29th, Thomas Kosasa purchased 581,395 shares of OneMedNet stock. The shares were purchased at an average price of $0.86 per share, for a total transaction of $499,999.70.

OneMedNet Stock Performance

Shares of OneMedNet stock traded down $0.04 on Thursday, hitting $1.42. The stock had a trading volume of 298,140 shares, compared to its average volume of 762,577. The stock has a 50 day moving average of $1.77 and a 200 day moving average of $0.99. The firm has a market capitalization of $72.43 million, a P/E ratio of -28.40 and a beta of 1.09. OneMedNet Corporation has a twelve month low of $0.30 and a twelve month high of $4.22.

OneMedNet (NASDAQ:ONMD) last posted its earnings results on Friday, November 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.18 million for the quarter.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ONMD shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of OneMedNet in a report on Tuesday, October 14th. Wall Street Zen raised shares of OneMedNet to a “hold” rating in a research report on Friday, September 26th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

Institutional Investors Weigh In On OneMedNet

Institutional investors have recently added to or reduced their stakes in the company. Ashton Thomas Private Wealth LLC bought a new position in shares of OneMedNet during the 3rd quarter worth approximately $25,000. Exencial Wealth Advisors LLC increased its position in shares of OneMedNet by 3.1% during the second quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company’s stock valued at $851,000 after acquiring an additional 45,448 shares during the last quarter. Finally, Correct Capital Wealth Management purchased a new stake in shares of OneMedNet during the third quarter valued at approximately $4,910,000. 0.95% of the stock is owned by institutional investors.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.